Role of IL-10 -1082, IFN-γ +874, and TNF-α -308 genes polymorphisms in suicidal behavior

Archives of Suicide Research

Volumn 13, Issue 4, 2009, Pages 330-339

  Omrani Dr , Mir Davood ^a   Bushehri, Behzad ^b   Bagheri, Morteza ^a   Salari Lak, Shaker ^b   Alipour, Azize ^a   Anoshae, Mohamad Reza ^b   Massomi, Reza ^c  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Department of Legal Justice and Forensic Medicine ^*  (Iran)

Author keywords

IFN +874; IL 10 1082; Suicide behavior; TNF 308

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOMUTILATION; COMPARATIVE STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; IRAN; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SUICIDE;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; IRAN; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SELF-INJURIOUS BEHAVIOR; SUICIDE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70350383464     PISSN: 13811118     EISSN: 15436136     Source Type: Journal    
DOI: 10.1080/13811110903266418     Document Type: Article

References (46)

1. Abraham, L. J., French, M. A., & Dawkins, R. L. (1993). Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-alpha. Clinical and Experimental Immunology, 92, 14-18.
2. Alkelai, A., Baum, A., Carless, M., et al. (2007). The XVth World Congress of Psychiatric Genetics, October 7-11, 2007: Rapporteur summaries of oral presentations. American Journal of Medical Genetics, 147B(2), 233-277.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press.
4. Balthazart, J., Foidart, A., Absil, P., et al. (1996). Effects of testosterone and its metabolites on aromatase-immunoreactive cells in the quail brain: Relationship with the activation of male reproductive behavior. Journal of Steroid Biochemistry & Molecular Biology, 48, 185-200.
5. Beautrais, A. L. (2000). Risk factors for suicide and attempted suicide among young people. Australian and New Zealand Journal of Psychiatry, 34, 420-436.
6. Beautrais, A. L. (2003). Subsequent mortality in medically serious suicide attempts: A 5year follow-up. Australian and New Zealand Journal of Psychiatry, 37(5), 595-599.
7. Berk, M., Wadee, A. A., Kuschke, R. H., et al. (1997). Acute phase proteins in major depression. Journal of Psychosomatic Research, 43, 529-534.
8. Brent, D. A., Perper, J. A., Goldstein, C. E., et al. (1988). Risk factors for adolescent suicide. A comparison of adolescent suicide victims with suicidal inpatients. Archives of General Psychiatry, 45, 581-588.
9. Brent, D. A., Perper, J. A., Moritz, G., et al. (1993). Firearms and adolescent suicide. A community case-control study. American Journal of Diseases of Children, 147(10), 1066-1071.
10. Capuron, L., Ravaud, A., Gualde, N., et al. (2001). Association between immune activation and early depressive symptoms in cancer patients treated with IL-2-based therapy. Psychoneuroendocrinology, 26,797-808.
11. Connor, T. J., & Leonard, B. E. (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Sciences, 62(7),583-606.
12. Dantzer, R., Wollman, E., Vitkovic, L., et al. (1999). Cytokines and depresion: fortuitous or causative association? Molecular Psychiatry, 4, 328-332.
13. Dauvilliers, Y., Neidhart, E., Lecendreux, M., et al. (2001). MAO-A and COMT polymorphisms and gene effects in narcolepsy. Molecular Psychiatry, 6, 367-372.
14. Gogos, J. A., Morgan, M., Luine, V., et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the United States of America, 95, 9991-9996.
15. Graham, C., & Burvill, P. W. (1992). A study of coroner's records of suicide in young people, 1986-88 in Western Australia. Australian and New Zealand Journal of Psychiatry, 26, 30-39.
16. Hollegaard, M. V., & Bidwell, J. L. (2006). Cytokine gene polymorphism in human disease: Online databases, Supplement 3. Genes and Immunity, 7, 269-276.
17. Huang, D. R., Zhou, Y. H., Xia, S. Q., et al. (1999). Markers in the promoter region of interleucin 10 gene in myasthenia gravis: Implications of diverse effects of IL-10 in the pathogenesis of the disease. Journal of Neuroimmunology, 94, 82-87.
18. Huang, S., Ullrich, S. E., & Ber-Eli, M. (1999). Regulation of tumor growth and metastasis by IL-10: The melanoma experience. Journal of Interferon and Cytokine Research, 19, 697-703.
19. Huang, T. L., & Lee, C. T. (2007). T-helper 1=T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry and Clinical Neurosciences, 61(4), 415-420.
20. Jun, T. Y., Pae, C. U., Chae, J. H., et al. (2003). Tumor necrosis factor-b gene polymorphism may not be associated with major depressive disorder in the Korean population. Psychiatry and Clinical Neurosciences, 57, 31-35.
21. Keso, T., Perola, M., Laippala, P., et al. (2001). Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis, 154, 691-697.
22. Kronfol, Z., & Remick, D. G. (2000). Cytokines and the brain: Implications for clinical psychiatry. The American Journal of Psychiatry, 157, 683-694.
23. Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U., et al. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsycho-pharmacology, 22(4), 370-379.
24. Licinio, J., & Wong, M. L. (1999). The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Molecular Psychiatry, 4, 317-327.
25. Maes, M., Bosmans, E., Suy, E., et al. (1991). Depression-related disturbances in mitogen-induced lymphocyte responses and IL-1 beta and soluble IL-2 receptor production. Acta Psychiatrica Scandinavica, 84(4), 379-386.
26. Mann, J. J., Waternaux, C., Haas, G. L., et al. (1999). Toward a Clinical model of suicidal behavior in psychiatric patients. The American Journal of Psychiatry, 156, 181-189.
27. Mikova, O., Yakimova, R., Bosmans, E., et al. (2001). Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. European Neuropsychopharmacology, 11, 203-208.
28. Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
29. Muller, N., & Ackenheil, M. (1998). Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Progress in Neuro-psychopharmacology & Biological Psychiatry, 22(1),1-33.
30. Ozaki, K., & Leonard, W. J. (2002). Cytokine and cytokine receptor: Pleiotropy and redundancy. Journal of Biological Chemistry, 277(33), 29355-29358.
31. Pilar, A. S., Paz, G. P., Begona, P., et al. (2008). Association study of the IL-1 gene complex and tumor necrosis factor alpha gene with suicide attempts. Psychiatric Genetics, 18(3), 147-150.
32. Pollmacher, T., Haack, M., Schuld, A., et al. (2000). Effects of antipsychotic drugs on cytokine networks. Journal of Psychiatric Research, 34, 369-382.
33. Posner, K., Oquendo, M. A., Gould M., et al. (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA's Pediatric Suicidal Risk Analysis of Antidepressants. American Journal of Psychiatry, 164, 1035-1043.
34. Pravica, V., Perrey, C., Stevens, A., et al. (2000). A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Human Immunology, 61, 863-866.
35. Qian, Q., Wang, Y., Zhou, R., et al. (2003). Family based and case-control association studies of catechol-o-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. American Journal of Medical Genetics, 118B, 103-109.
36. Roy, A. (1986). Genetics of suicide. Annals of the New York Academy of Sciences, 487, 97-105.
37. Roy, A., Segal, N. L., Centerwall, B. S., et al. (1991). Suicide in twins. Archives of General Psychiatry, 48, 29-32.
38. Rujescu, D., Giegling, I., Gietl, A., et al. (2003). A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biological Psychiatry, 54,34-39.
39. Salari-Lak, S., Entezarmahdi, R., Afshani, M., et al. (2006). Survey of rate and effective factors on occurrence of suicide during one year in west-azarbaijan. Urmia Medical Journal, 17(2), 152-153.
40. Schulsinger, F., Kety, S. S., Rosenthal, D., et al. (1979). A family study of suicide. In M. Schou & E. Stromgren (Eds.), Origin, prevention, and treatment of affective disorders (pp.277-287). New York: Academic Press.
41. Statham, D. J., Heath, A. C., Madden, P. A. F., et al. (1998). Suicidal behaviour: Anepidemiological and genetic study. Psychological Medicine, 28, 839-855.
42. Tonelli, L. H., Stiller, J., Rujescu, D., et al. (2008). Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatrica Scandinavica, 117(3), 198-206.
43. Turner, D. M., Williams, D. M., Sankaran, D., et al. (1997). An investigation of polymorphism in the IL-10 gene promoter. European Journal of Immunogenetics, 24, 1-8.
44. Verjans, G. M., Brinkman, B. M., VanDoornik, C. E., et al. (1994). Polymorphism of tumor necrosis factor-alpha (TNF-alpha) at position 308 in relation to ankylosing spondylitis. Clinical and Experimental Immunology, 97, 45-47.
45. Weizman, R., Laor, N., Podliszewski, E., et al. (1994). Cytokine production in major depressed patients before and after clomipramine treatment. Biological Psychiatry, 35, 42-47.
46. Woodroofe, M. N. (1995). Cytokine production in the central nervous system. Neurology, 45(6), S6-S10.